Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
David I. Chemerow is Director at Aim Immunotech. OQRO lists 5 transactions filed with the SEC under this name, the latest on Mar 16, 2026, each linked to the official Form 4.
Director
Disclosures on record
5
Companies involved
1
Aim ImmunotechAIM
5 disclosures · Feb 2026 – Mar 2026
Mar 12, 202625Kdisclosed Mar 16
DetailsOfficial recordMar 12, 202625disclosed Mar 16
DetailsOfficial recordMar 6, 202650Kdisclosed Mar 10
DetailsOfficial recordMar 6, 202625disclosed Mar 10
DetailsOfficial recordFeb 5, 20262,800disclosed Feb 6
DetailsOfficial recordAs of the latest filing on , David I. Chemerow reported holding 31,882 shares of Aim Immunotech (AIM), worth about $4.6K at the last close of $0 (Nov 13, 2026): 28,441 held directly and 3,441 through a the david i chemerow 1992 trust.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aim Immunotech AIM | 31,882 | 28K direct · 3,441 the david i chemerow 1992 trust | $0 | $4.6K | Mar 12, 2026 |
Is this David I. Chemerow’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Mar 12, 2026, David I. Chemerow reported holding 31,882 shares of Aim Immunotech (AIM), of which 3,441 are held indirectly. At the last close of $0 on Nov 13, 2026, that is about $4.6K. This is the stake disclosed in filings, not a net worth.